Archives: “Archives”

Showing 51 - 60 of 128 posts

Early Detection and Diagnosis of Autoimmune Diseases Using Foundation AI Models

https://www.coltonconsortium.org/projects/early-detection-and-diagnosis-of-autoimmune-diseases-using-foundation-ai-models/

Applying self-supervised AI to multi-modal electronic health records — integrating clinical notes, labs, and imaging — this project builds scalable diagnostic models to detect autoimmune diseases earlier and more precisely.

The Role and Mechanism of Aberrant Dendritic Cell Function in Autoimmunity

https://www.coltonconsortium.org/projects/the-role-and-mechanism-of-aberrant-dendritic-cell-function-in-autoimmunity/

Identifying a novel molecular regulator of tolerogenic dendritic cell function, this project uncovers how its loss triggers spontaneous multiorgan autoimmunity and exacerbates lupus — revealing a clinically relevant pathway in immune tolerance.

The Epidermis as a Novel Therapeutic Target in Pemphigus Vulgaris

https://www.coltonconsortium.org/projects/the-epidermis-as-a-novel-therapeutic-target-in-pemphigus-vulgaris/

By profiling genetic and molecular drivers of pemphigus vulgaris across patient skin and blood, this project uncovers genotype-driven inflammatory loops and actionable targets for personalized therapy.

Developing a Multi-parameter Prognostic Prediction Model for Disability Ranks and Progression of Patients with Multiple Sclerosis at the Early Stages of the Disease

https://www.coltonconsortium.org/projects/developing-a-multi-parameter-prognostic-prediction-model-for-disability-ranks-and-progression-of-patients-with-multiple-sclerosis-at-the-early-stages-of-the-disease/

Integrating clinical, imaging, and biological data from large real-world MS cohorts, this project builds a machine learning model to predict disability progression early and enable personalized treatment decisions.

Immunotherapy-Related Adverse Effects as Models for Fragile Tolerance in Humans

https://www.coltonconsortium.org/projects/immunotherapy-related-adverse-effects-as-models-for-fragile-tolerance-in-humans/

Using cancer patients experiencing immunotherapy-triggered autoimmunity as a unique human model, this project uncovers the molecular and epigenetic mechanisms by which self-reactive T cells escape immune tolerance.

The Role of Glycosylation in Inflammatory Bowel Disease

https://www.coltonconsortium.org/projects/the-role-of-glycosylation-in-inflammatory-bowel-disease/

Investigating how foreign sugar modifications on anti-TNF biologics trigger immune responses in pediatric IBD patients, this project aims to personalize biologic therapy selection and inform safer drug design.

Shedding Light on the Invisible: A New Paradigm for Predicting Multiple Sclerosis Disease Progression Using Novel MRI Tools for Probing Pathology in Normal Appearing Tissues

https://www.coltonconsortium.org/projects/shedding-light-on-the-invisible-a-new-paradigm-for-predicting-multiple-sclerosis-disease-progression-using-novel-mri-tools-for-probing-pathology-in-normal-appearing-tissues/

Applying advanced quantitative MRI to detect pathology invisible to current clinical tools, this project builds an AI model to predict MS progression and enable earlier, more personalized diagnosis and treatment.

Defining Endotypes in Hidradenitis Suppurativa to Improve Treatment

https://www.coltonconsortium.org/projects/defining-endotypes-in-hidradenitis-suppurativa-to-improve-treatment/

Using spatial transcriptomics to map distinct HS disease endotypes and identify targeted therapeutic strategies for this underserved inflammatory skin disease.

Developing a Non-Invasive Biomarker Test to Classify Lupus Nephritis

https://www.coltonconsortium.org/projects/developing-a-non-invasive-biomarker-test-to-classify-lupus-nephritis/

Identifying DNA methylation signatures in blood and urine as non-invasive biomarkers to classify lupus nephritis and guide treatment without repeated biopsies.